{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T16:54:01Z","timestamp":1790873641144,"version":"4.1.0"},"reference-count":31,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2018,12,19]],"date-time":"2018-12-19T00:00:00Z","timestamp":1545177600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2019,12,19]],"date-time":"2019-12-19T00:00:00Z","timestamp":1576713600000},"content-version":"am","delay-in-days":365,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#am"},{"start":{"date-parts":[[2018,12,19]],"date-time":"2018-12-19T00:00:00Z","timestamp":1545177600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["17K08452"],"award-info":[{"award-number":["17K08452"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Clin Pharm Ther"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1111\/jcpt.12790","type":"journal-article","created":{"date-parts":[[2018,12,20]],"date-time":"2018-12-20T04:39:10Z","timestamp":1545280750000},"page":"285-291","source":"Crossref","is-referenced-by-count":17,"title":["Evaluation of pregabalin-induced adverse events related to falls using the FDA adverse event reporting system and Japanese Adverse Drug Event Report databases"],"prefix":"10.1155","volume":"44","author":[{"given":"Ririka","family":"Mukai","sequence":"first","affiliation":[{"name":"Laboratory of Drug Informatics; Gifu Pharmaceutical University; Gifu Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiori","family":"Hasegawa","sequence":"additional","affiliation":[{"name":"Laboratory of Drug Informatics; Gifu Pharmaceutical University; Gifu Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryogo","family":"Umetsu","sequence":"additional","affiliation":[{"name":"Laboratory of Drug Informatics; Gifu Pharmaceutical University; Gifu Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Nakao","sequence":"additional","affiliation":[{"name":"Laboratory of Drug Informatics; Gifu Pharmaceutical University; Gifu Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuyo","family":"Shimada","sequence":"additional","affiliation":[{"name":"Laboratory of Drug Informatics; Gifu Pharmaceutical University; Gifu Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Uranishi","sequence":"additional","affiliation":[{"name":"Laboratory of Drug Informatics; Gifu Pharmaceutical University; Gifu Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayuko","family":"Masuta","sequence":"additional","affiliation":[{"name":"Laboratory of Drug Informatics; Gifu Pharmaceutical University; Gifu Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Honami","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Laboratory of Drug Informatics; Gifu Pharmaceutical University; Gifu Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuri","family":"Nishibata","sequence":"additional","affiliation":[{"name":"Laboratory of Drug Informatics; Gifu Pharmaceutical University; Gifu Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5062-5522","authenticated-orcid":false,"given":"Mitsuhiro","family":"Nakamura","sequence":"additional","affiliation":[{"name":"Laboratory of Drug Informatics; Gifu Pharmaceutical University; Gifu Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2018,12,19]]},"reference":[{"key":"10.1111\/jcpt.12790-BIB0001|jcpt12790-cit-0001","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.seizure.2005.11.005","article-title":"Pregabalin: a new antiepileptic drug for refractory epilepsy","volume":"15","author":"Hamandi","year":"2006","journal-title":"Seizure"},{"key":"10.1111\/jcpt.12790-BIB0002|jcpt12790-cit-0002","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.pain.2007.08.033","article-title":"Pharmacologic management of neuropathic pain: evidence-based recommendations","volume":"132","author":"Dworkin","year":"2007","journal-title":"Pain"},{"issue":"17","key":"10.1111\/jcpt.12790-BIB0003|jcpt12790-cit-0003","first-page":"1113-e88","article-title":"EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision","volume":"2010","author":"Attal","year":"2010","journal-title":"Eur J Neurol"},{"key":"10.1111\/jcpt.12790-BIB0004|jcpt12790-cit-0004","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/syn.10094","article-title":"Preferential action of gabapentin and pregabalin at P\/Q-type voltage-sensitive calcium channels: inhibition of K+-evoked [3H]-norepinephrine release from rat neocortical slices","volume":"45","author":"Dooley","year":"2002","journal-title":"Synapse"},{"issue":"Suppl 6","key":"10.1111\/jcpt.12790-BIB0005|jcpt12790-cit-0005","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.0013-9580.2004.455003.x","article-title":"Pregabalin pharmacology and its relevance to clinical practice","volume":"45","author":"Ben-Menachem","year":"2004","journal-title":"Epilepsia"},{"key":"10.1111\/jcpt.12790-BIB0006|jcpt12790-cit-0006","unstructured":"Parke-Davis, Division of Pfizer Inc Highlights of prescribing information, lyrica (pregabalin) capsules, lyrica (pregabalin) oral solutions https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2011\/021446s026,022488s005lbl.pdf"},{"key":"10.1111\/jcpt.12790-BIB0007|jcpt12790-cit-0007","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.seizure.2008.09.004","article-title":"Add-on treatment with pregabalin for partial seizures with or without generalisation: pooled data analysis of four randomised placebo-controlled trials","volume":"18","author":"Gil-Nagel","year":"2009","journal-title":"Seizure"},{"key":"10.1111\/jcpt.12790-BIB0008|jcpt12790-cit-0008","doi-asserted-by":"crossref","first-page":"439","DOI":"10.2147\/JPR.S63028","article-title":"An open-label, long-term study examining the safety and tolerability of pregabalin in Japanese patients with central neuropathic pain","volume":"7","author":"Onouchi","year":"2014","journal-title":"J Pain Res"},{"key":"10.1111\/jcpt.12790-BIB0009|jcpt12790-cit-0009","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/papr.12146","article-title":"A comprehensive drug safety evaluation of pregabalin in peripheral neuropathic pain","volume":"15","author":"Freynhagen","year":"2015","journal-title":"Pain Pract"},{"key":"10.1111\/jcpt.12790-BIB0010|jcpt12790-cit-0010","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1007\/s40266-014-0225-x","article-title":"Medication-related fall incidents in an older, ambulant population: the B-PROOF study","volume":"31","author":"Ham","year":"2014","journal-title":"Drugs Aging"},{"key":"10.1111\/jcpt.12790-BIB0011|jcpt12790-cit-0011","first-page":"2927","article-title":"Role of pregabalin in treatment of oxaliplatin-induced sensory neuropathy","volume":"30","author":"Saif","year":"2010","journal-title":"Anticancer Res"},{"key":"10.1111\/jcpt.12790-BIB0012|jcpt12790-cit-0012","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2174\/1876386301205010001","article-title":"Pregabalin in neuropathic pain related to DPN, cancer and back pain: analysis of a 6-week observational study","volume":"5","author":"Toelle","year":"2012","journal-title":"Open Pain J"},{"key":"10.1111\/jcpt.12790-BIB0013|jcpt12790-cit-0013","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s40780-015-0022-7","article-title":"A retrospective study to identify risk factors for somnolence and dizziness in patients treated with pregabalin","volume":"1","author":"Kato","year":"2015","journal-title":"J Pharm Health Care Sci"},{"key":"10.1111\/jcpt.12790-BIB0014|jcpt12790-cit-0014","first-page":"265","article-title":"Data Mining Techniques in Pharmacovigilance: Analysis of the Publicly Accessible FDA Adverse Event Reporting System (AERS)","author":"Poluzzi","year":"2012","journal-title":"INECH"},{"key":"10.1111\/jcpt.12790-BIB0015|jcpt12790-cit-0015","doi-asserted-by":"crossref","first-page":"796","DOI":"10.7150\/ijms.6048","article-title":"Data mining of the public version of the FDA adverse event reporting system","volume":"10","author":"Sakaeda","year":"2013","journal-title":"Int J Med Sci"},{"key":"10.1111\/jcpt.12790-BIB0016|jcpt12790-cit-0016","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1248\/yakushi.15-00224-5","article-title":"Analysis of spontaneously reported adverse events","volume":"136","author":"Nakamura","year":"2016","journal-title":"Yakugaku Zasshi"},{"key":"10.1111\/jcpt.12790-BIB0017|jcpt12790-cit-0017","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1111\/jcpt.12683","article-title":"Adverse drug event profile associated with pregabalin among patients with and without cancer: analysis of a spontaneous reporting database","volume":"43","author":"Kose","year":"2018","journal-title":"J Clin Pharm Ther"},{"key":"10.1111\/jcpt.12790-BIB0018|jcpt12790-cit-0018","unstructured":"U. S. Food and Drug Administration \u201cREADME.DOC\u201d file for the quarterly data extract (QDE) from the FDA adverse event reporting system (FAERS) http:\/\/www.fda.gov\/Drugs\/GuidanceComplianceRegulatoryInformation\/Surveillance\/AdverseDrugEffects\/ucm082193.htm"},{"key":"10.1111\/jcpt.12790-BIB0019|jcpt12790-cit-0019","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/pds.668","article-title":"A comparison of measures of disproportionality for signal detection in spontaneous reporting systems for adverse drug reactions","volume":"11","author":"Puijenbroek","year":"2002","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1111\/jcpt.12790-BIB0020|jcpt12790-cit-0020","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/s002280000215","article-title":"Detecting drug-drug interactions using a database for spontaneous adverse drug reactions: an example with diuretics and non-steroidal anti-inflammatory drugs","volume":"56","author":"Puijenbroek","year":"2000","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1111\/jcpt.12790-BIB0021|jcpt12790-cit-0021","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1248\/bpb.b14-00191","article-title":"Analysis of the interaction between clopidogrel, aspirin and proton pump inhibitors using the FDA adverse event reporting system database","volume":"38","author":"Suzuki","year":"2015","journal-title":"Biol Pharm Bull"},{"key":"10.1111\/jcpt.12790-BIB0022|jcpt12790-cit-0022","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1177\/0091270009352087","article-title":"Clinical pharmacokinetics of pregabalin in healthy volunteers","volume":"50","author":"Bockbrader","year":"2010","journal-title":"J Clin Pharmacol"},{"key":"10.1111\/jcpt.12790-BIB0023|jcpt12790-cit-0023","unstructured":"National Health Service, Lancashire Medicines Management Group The pharmacological management of neuropathic pain in adults http:\/\/www.lancsmmg.nhs.uk\/wp-content\/uploads\/sites\/3\/2013\/04\/Neuropathic-Pain-in-Adults-Prescribing-Guidance-Version-1.01.pdf"},{"key":"10.1111\/jcpt.12790-BIB0024|jcpt12790-cit-0024","unstructured":"National Health Service, Northern Lincolnshire Area Prescribing Committee Guideline for the treatment of neuropathic pain for adults in primary care http:\/\/www.northernlincolnshireapc.nhs.uk\/wp-content\/uploads\/Pathways\/Neuropathic_Pain\/Guideline_for_the_Treatment_of_Adult_Neuropathic_Pain.pdf"},{"key":"10.1111\/jcpt.12790-BIB0025|jcpt12790-cit-0025","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1001\/archinternmed.2009.357","article-title":"Meta-analysis of the impact of 9 medication classes on falls in elderly persons","volume":"169","author":"Woolcott","year":"2009","journal-title":"Arch Intern Med"},{"key":"10.1111\/jcpt.12790-BIB0026|jcpt12790-cit-0026","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1471-2318-9-30","article-title":"Inappropriate medication use and risk of falls-a prospective study in a large community-dwelling elderly cohort","volume":"9","author":"Berdot","year":"2009","journal-title":"BMC Geriatr"},{"key":"10.1111\/jcpt.12790-BIB0027|jcpt12790-cit-0027","first-page":"10","article-title":"Clinical and economic outcomes associated with potentially inappropriate prescribing in the elderly","volume":"16","author":"Stockl","year":"2010","journal-title":"Am J Manag Care"},{"key":"10.1111\/jcpt.12790-BIB0028|jcpt12790-cit-0028","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1111\/j.1365-2125.2005.02543.x","article-title":"Polypharmacy and falls in the middle age and elderly population","volume":"61","author":"Ziere","year":"2006","journal-title":"Br J Clin Pharmacol"},{"key":"10.1111\/jcpt.12790-BIB0029|jcpt12790-cit-0029","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1093\/gerona\/62.10.1172","article-title":"Medication as a risk factor for falls: critical systematic review","volume":"62","author":"Hartikainen","year":"2007","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"10.1111\/jcpt.12790-BIB0030|jcpt12790-cit-0030","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/j.1447-0594.2011.00783.x","article-title":"Polypharmacy as a risk for fall occurrence in geriatric outpatients","volume":"12","author":"Kojima","year":"2012","journal-title":"Geriatr Gerontol Int"},{"key":"10.1111\/jcpt.12790-BIB0031|jcpt12790-cit-0031","doi-asserted-by":"crossref","first-page":"3031","DOI":"10.2147\/DDDT.S81998","article-title":"Effect of database profile variation on drug safety assessment: an analysis of spontaneous adverse event reports of Japanese cases","volume":"9","author":"Nomura","year":"2015","journal-title":"Drug Des Devel Ther"}],"container-title":["Journal of Clinical Pharmacy and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjcpt.12790","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/am-pdf\/10.1111%2Fjcpt.12790","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/jcpt.12790\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T18:04:06Z","timestamp":1671818646000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/jcpt.12790"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,19]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,4]]}},"URL":"https:\/\/doi.org\/10.1111\/jcpt.12790","archive":["Portico"],"relation":{},"ISSN":["0269-4727"],"issn-type":[{"value":"0269-4727","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12,19]]}}}